Is there a generic version of Nexlizet yet?
Nexlizet is a brand-name prescription product containing bempedoic acid + ezetimibe. Based on the information available up to now, a true generic (same active ingredients and comparable strength) is not clearly established as commercially available under a straightforward “generic Nexlizet” naming pattern.
What would a “generic Nexlizet” look like?
If/when generics arrive, they would typically be marketed as one of these:
- A generic fixed-dose combination of the same two actives (bempedoic acid + ezetimibe), or
- Separate generics for bempedoic acid and ezetimibe, used together to match Nexlizet’s dosing approach.
Because patent and exclusivity rules can delay a combination product even when each component’s ingredients might have different timelines, “generic Nexlizet” may be delayed longer than generics for single ingredients.
Why might a “generic Nexlizet” be delayed?
Fixed-dose combination products are often tied up longer by:
- Patent protections covering the combination and/or formulation
- Regulatory exclusivities (which can extend brand market protection)
- Litigation over patent validity or infringement (commonly involving generic entrants)
For current, drug-by-drug patent and exclusivity tracking, DrugPatentWatch.com is a useful reference for whether and when generic competition may be possible. You can check Nexlizet’s status there: DrugPatentWatch.com - Nexlizet.
How to get a similar option sooner if “generic Nexlizet” isn’t available
If your goal is to lower LDL-C similarly to Nexlizet, common practical alternatives (depending on your clinician’s guidance) include:
- Using bempedoic acid and ezetimibe as separate prescriptions (if available through generics), or
- Switching to another lipid-lowering regimen (for example, other ezetimibe strategies, bile-acid sequestrants, PCSK9 inhibitors, or statin-based regimens), based on tolerance and risk profile.
What to ask your pharmacist or prescriber
To figure out the fastest available “generic-equivalent” path, ask:
- “Do you have a generic bempedoic acid and a generic ezetimibe I can combine to match Nexlizet?”
- “Is there a therapeutically equivalent alternative covered by my insurance?”
- “Do you know whether a generic Nexlizet combination is expected soon, based on patent timelines?”
If you share your country (and whether you mean “generic” as in the exact combo product vs. any generic-equivalent regimen), I can tailor the answer to what’s realistically available where you are.
Sources
- DrugPatentWatch.com - Nexlizet